Oct 19, 2022 – The protocol of the multicenter, randomized clinical trial HEMOTION (Hemoglobin transfusion threshold in traumatic brain injury optimization) has been published in the BMJ Open: https://bmjopen.bmj.com/content/12/10/e067117
The primary objective of this international pragmatic randomized open label blinded-endpoint trial is to evaluate whether a liberal (higher hemoglobin [Hb] threshold) versus a restrictive (lower Hb threshold) red blood cell transfusion strategy improves neurological outcomes in anemic moderate and severe TBI patients admitted to the intensive care unit.
Two of our researchers, i.e. Dr. François Lauzier and Dr. Alexis Turgeon are leading the project and our clinical research team is involved in this clinical trial.
